UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.

Wolinsky, JS; Narayana, PA; O'Connor, P; Coyle, PK; Ford, C; Johnson, K; ... PROMiSe Trial Study Group,; + view all (2007) Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial. Ann Neurol , 61 (1) 14 - 24. 10.1002/ana.21079.

Full text not available from this repository.

Abstract

To determine whether glatiramer acetate (GA) slows accumulation of disability in primary progressive multiple sclerosis.

Type:Article
Title:Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.
Location:United States
DOI:10.1002/ana.21079
Language:English
Keywords:Adult, Disability Evaluation, Double-Blind Method, Female, Follow-Up Studies, Humans, Immunosuppressive Agents, International Cooperation, Male, Middle Aged, Multiple Sclerosis, Chronic Progressive, Peptides, Proportional Hazards Models, Retrospective Studies, Severity of Illness Index, Sex Factors
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Brain Sciences

Archive Staff Only: edit this record